Zhiyi Chen Selected Research

Zhiyi Chen Research Topics

Disease

15	Neoplasms (Cancer) 10/2022 - 11/2009
5	Infections 03/2022 - 12/2006
4	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 10/2018
3	Coma (Comas) 08/2019 - 10/2009
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 09/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2017
1	Premature Birth (Birth, Premature) 11/2022
1	Body Weight (Weight, Body) 05/2022
1	Bacterial Infections (Bacterial Infection) 03/2022
1	Glioma (Gliomas) 01/2022
1	Alopecia (Baldness) 03/2021
1	Dandruff 03/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Obesity 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cleft Lip (Harelip) 11/2018
1	Infarction (Infarctions) 03/2018
1	Cerebral Infarction 03/2018
1	Ischemic Stroke 03/2018
1	Graves Ophthalmopathy 01/2018
1	Margins of Excision 10/2017
1	Hemorrhage 10/2017
1	Anastomotic Leak 10/2017
1	Pathologic Constriction (Stenosis) 10/2017
1	Ileus 10/2017
1	Hemolysis 01/2017
1	Carcinogenesis 07/2014
1	Ovarian Epithelial Carcinoma 07/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
5	Biological ProductsIBA 03/2021 - 10/2009
2	Oxygen (Dioxygen)IBA 03/2022 - 11/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 11/2020
2	SolutionsIBA 03/2021 - 11/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 03/2018
2	Amino Acids FDA Link 02/2010 - 10/2009
1	emu OilIBA 05/2022
1	hematoporphyrin monomethyl etherIBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Hemoglobins (Hemoglobin)IBA 03/2022
1	Protein Sorting Signals (Signal Peptide)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	timosaponin B-IIIBA 03/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2021
1	LipidsIBA 03/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	CarcinogensIBA 01/2021
1	furanIBA 01/2021
1	matrigelIBA 01/2021
1	Galectin 1 (LGALS1)IBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2021
1	protoporphyrin IXIBA 11/2020
1	PAsp(DET)IBA 11/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	enhanced green fluorescent proteinIBA 01/2020
1	Biocompatible Materials (Biomaterials)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	HydrogelsIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	OligopeptidesIBA 08/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Molecular Probes (Molecular Probe)IBA 01/2019
1	GasesIBA 01/2019
1	CXC ChemokinesIBA 09/2018
1	N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA 09/2018
1	Neuroprotective AgentsIBA 03/2018
1	Kallikreins (Kallikrein)IBA 03/2018
1	Troleandomycin (TAO)FDA Link 01/2018
1	AntigensIBA 01/2018
1	Complement C3 (C3 Complement)IBA 01/2017
1	XELOXIBA 09/2016
1	RNA (Ribonucleic Acid)IBA 11/2015
1	Long Noncoding RNAIBA 07/2014
1	Polysaccharides (Glycans)IBA 05/2014
1	Aspartic Acid (Aspartate)FDA Link 02/2010
1	PolyethyleneimineIBA 12/2009
1	contrast agent BR1IBA 11/2009
1	Small Interfering RNA (siRNA)IBA 11/2009

Therapy/Procedure

12	Therapeutics 10/2022 - 11/2009
7	Microbubbles 01/2021 - 11/2009
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2016
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 11/2020
2	Radiotherapy 01/2022 - 01/2019
2	Lymph Node Excision (Lymph Node Dissection) 10/2017 - 09/2016
1	Cervical Cerclage 11/2022
1	Photothermal Therapy 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Precision Medicine 01/2022
1	Lasers (Laser) 11/2020
1	Alveolar Bone Grafting 11/2018
1	Immunotherapy 01/2018
1	Ligation 10/2017
1	Neoadjuvant Therapy 10/2017